Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Language
Publication year range
1.
J Pediatr ; 253: 297-303.e6, 2023 02.
Article in English | MEDLINE | ID: mdl-36152688

ABSTRACT

Cross-sectional analyses of 4 nationally representative samples indicate disparities in family-centered care occur among US children and youth with special healthcare needs by race and ethnicity, family income and composition, insurance coverage, and healthcare setting. Measured confounds including children's health and impairment severity do not explain the disparities.


Subject(s)
Ethnicity , Health Services Accessibility , Child , Humans , Adolescent , United States , Cross-Sectional Studies , Income , Patient-Centered Care , Healthcare Disparities
2.
J Pediatr ; 233: 150-155.e4, 2021 06.
Article in English | MEDLINE | ID: mdl-33631166

ABSTRACT

OBJECTIVES: To investigate the efficacy and safety of sirolimus in the treatment of cardiac rhabdomyomas associated with tuberous sclerosis complex and the specific benefits in different subgroups. STUDY DESIGN: The study was a prospective cohort and self-controlled case series study. Based on the prevalence of cardiac rhabdomyoma at different ages, we estimated the natural tumor disappearance rate. The subgroup analysis was done by Cox regression. Self-controlled case series method was used to assess the magnitude and duration of the drug effect. Adverse events were described. RESULTS: A total of 217 patients were included in the cohort study. Tumor disappearance rate was higher in younger age groups (hazard ratio = 0.99, P = .027) and female patients (hazard ratio = 2.08, P = .015). The age-adjusted incidence ratio showed that the disappearance of rhabdomyomas between 3 and 6 months was more related to sirolimus. Adverse events were observed 60 times in 42 of 217 children, mainly stomatitis. CONCLUSIONS: Sirolimus can increase the disappearance rate of cardiac rhabdomyoma in the tuberous sclerosis complex population. Efficacy varies by sex and age: female and younger patients have higher tumor disappearance rate. Sirolimus is well-tolerated.


Subject(s)
Antibiotics, Antineoplastic/therapeutic use , Heart Neoplasms/drug therapy , Rhabdomyoma/drug therapy , Sirolimus/therapeutic use , Tuberous Sclerosis/complications , Age Factors , Child, Preschool , Cohort Studies , Female , Heart Neoplasms/etiology , Humans , Infant , Male , Rhabdomyoma/etiology , Sex Factors
3.
Braz J Microbiol ; 51(3): 1145-1150, 2020 Sep.
Article in English | MEDLINE | ID: mdl-31836963

ABSTRACT

Bacillus sp. strain QHF158, a Gram-positive, spore-forming and parasporal crystal-secreting bacterium, was isolated from soil of Limushan National Forest Park in China. Here we present the significant feature of parasporal inclusions of this organism, together with the draft genome sequence and annotation. Phylogenetic analysis suggested that strain QHF158 is possibly a novel species, most closely related to Bacillus mycoides. Genome annotation results revealed that strain QHF158 did not contain any typical Cry or Cyt toxin coding gene. Furthermore, the mass spectrometry analyses demonstrated that the parasporal crystalline inclusions were encoded by the orf_05273 gene, with 95% similarity to the S-layer protein (SLP) EA1 of B. mycoides, which indicated that the parasporal crystal from Bacillus sp. strain QHF158 was mainly formed by SLP, instead of the typical Cry or Cyt toxin proteins.


Subject(s)
Bacillus/genetics , Genome, Bacterial , Inclusion Bodies/metabolism , Membrane Glycoproteins/metabolism , Bacillus/classification , Bacillus/isolation & purification , Bacillus/metabolism , Inclusion Bodies/genetics , Membrane Glycoproteins/genetics , Phylogeny , Soil Microbiology
4.
Biol Res ; 51(1): 2, 2018 Jan 09.
Article in English | MEDLINE | ID: mdl-29316975

ABSTRACT

BACKGROUND: This study determined the regulatory effects of inducible T-cell co-stimulators (ICOS) in human hepatocellular carcinoma HepG2 cells using a RNA interference (RNAi) technique. METHODS: A RNAi technique was used to knockdown the expression of ICOS. ICOS expression after knockdown was detected as mRNA and protein levels by RT-PCR and Western blot, respectively. A MTT colorimetric assay was used to detect cell proliferation, and the Transwell assay was used to detect cell invasion. Western blot was carried out to detect the level of Bcl-2, AKT, and PI3K protein expression in different groups. RESULTS: The proliferation of HepG2 cells were significantly decreased after ICOS siRNA transfection (EG group). Similarly, the results of the Transwell experiment showed that invasion of HepG2 cells in the EG group was clearly reduced compared to the negative control (NC) and blank control groups (CON). Western blot analysis showed that knockdown of ICOS expression reduced the levels of Bcl-2 and AKT, and also significantly up-regulated the level of PI3K phosphorylation (P < 0.01). CONCLUSION: Down-regulating ICOS expression in HepG2 cells suppressed cell proliferation and invasion. The underlying mechanism may be related to the expression of the downstream factor, PI3K/AKT.


Subject(s)
Carcinoma, Hepatocellular/pathology , Gene Expression Regulation, Neoplastic/genetics , Inducible T-Cell Co-Stimulator Protein/physiology , Liver Neoplasms/pathology , Blotting, Western , Carcinoma, Hepatocellular/metabolism , Cell Proliferation , Colorimetry , Down-Regulation , Gene Knockdown Techniques , Hep G2 Cells , Humans , Inducible T-Cell Co-Stimulator Protein/genetics , Liver Neoplasms/metabolism , Neoplasm Invasiveness , Phosphatidylinositol 3-Kinases/blood , Proto-Oncogene Proteins c-akt/blood , Proto-Oncogene Proteins c-bcl-2/blood , RNA Interference , Reverse Transcriptase Polymerase Chain Reaction
5.
Biol. Res ; 51: 2, 2018. graf
Article in English | LILACS | ID: biblio-888428

ABSTRACT

Abstract Background This study determined the regulatory effects of inducible T-cell co-stimulators (ICOS) in human hepatocellular carcinoma HepG2 cells using a RNA interference (RNAi) technique. Methods A RNAi technique was used to knockdown the expression of ICOS. ICOS expression after knockdown was detected as mRNA and protein levels by RT-PCR and Western blot, respectively. A MTT colorimetric assay was used to detect cell proliferation, and the Transwell assay was used to detect cell invasion. Western blot was carried out to detect the level of Bcl-2, AKT, and PI3K protein expression in different groups. Results The proliferation of HepG2 cells were significantly decreased after ICOS siRNA transfection (EG group). Similarly, the results of the Transwell experiment showed that invasion of HepG2 cells in the EG group was clearly reduced compared to the negative control (NC) and blank control groups (CON). Western blot analysis showed that knockdown of ICOS expression reduced the levels of Bcl-2 and AKT, and also significantly up-regulated the level of PI3K phosphorylation (P < 0.01). Conclusion Down-regulating ICOS expression in HepG2 cells suppressed cell proliferation and invasion. The underlying mechanism may be related to the expression of the downstream factor, PI3K/AKT.


Subject(s)
Humans , Gene Expression Regulation, Neoplastic/genetics , Carcinoma, Hepatocellular/pathology , Inducible T-Cell Co-Stimulator Protein/physiology , Liver Neoplasms/pathology , Down-Regulation , Blotting, Western , Colorimetry , Carcinoma, Hepatocellular/metabolism , Proto-Oncogene Proteins c-bcl-2/blood , Phosphatidylinositol 3-Kinases/blood , Reverse Transcriptase Polymerase Chain Reaction , RNA Interference , Cell Proliferation , Proto-Oncogene Proteins c-akt/blood , Gene Knockdown Techniques , Hep G2 Cells , Inducible T-Cell Co-Stimulator Protein/genetics , Liver Neoplasms/metabolism , Neoplasm Invasiveness
SELECTION OF CITATIONS
SEARCH DETAIL